StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
UPDATE: Citi Downgrades Biogen (BIIB) to Neutral
October 23, 2017 6:26 AM
(Updated - October 23, 2017 7:17 AM EDT)
(updated to add analyst comment)Citi ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Downgrades
Next Articles
Biogen (BIIB) Reports AFFINITY Phase 2 Trial Initiation for Opicinumab (Anti-LINGO-1) in Multiple Sclerosis
October 25, 2017 5:56 AM
Piper Jaffray Assumes Biogen (BIIB) at Overweight
October 23, 2017 4:43 AM